Somatic G → T mutations in the APC and KRAS genes are frequently observed in such colorectal tumors in MAP patients [10, 17], and even in non-MAP patients, reduced MUTYH expression is associated with an increased number of somatic G → T mutations in prostate adenocarcinoma [35]. Here, KRAS is linked to colorectal neoplasm.